Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

TAP Uprima Erectile Dysfunction NDA Refiling Slated For 4Q, Abbott Says

Apr 15 2002

• By The Pink Sheet

Related Content

TAP Uprima 3 Mg Dose Studies To Be Completed This Summer; NDA Withdrawn

Jul 03 2000

Uprima Selective ED Population Should Be Reflected In Labeling, Cmte. Says

Apr 17 2000

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window